Results 201 to 210 of about 30,224 (246)
The value of morphology: osteoclast-like cells in soft tissue tumours. [PDF]
Al Khader A +7 more
europepmc +1 more source
European Medicines Agency approvals of new medicines in September and October 2025. [PDF]
Sepodes B, Burgos JG, Thirstrup S.
europepmc +1 more source
Successful treatment with tepotinib followed by pembrolizumab in pulmonary pleomorphic carcinoma harbouring a <i>MET</i> exon 14 skipping mutation: A case report. [PDF]
Tanaka S +17 more
europepmc +1 more source
Reconstruction of Recurrent First Metatarsal Giant Cell Tumor with Vascularized Metatarsal Transfer: Long-Term Functional Outcomes. [PDF]
Ramprasad J +3 more
europepmc +1 more source
A distinctive case of giant mastoid osteoma in a young adolescent female. [PDF]
Gupta G +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Bone and Joint Journal, 2023
Giant cell tumour of bone (GCTB) is a locally aggressive lesion that is difficult to treat as salvaging the joint can be associated with a high rate of local recurrence (LR). We evaluated the risk factors for tumour relapse after treatment of a GCTB of the limbs.
Anthony M Griffin +2 more
exaly +5 more sources
Giant cell tumour of bone (GCTB) is a locally aggressive lesion that is difficult to treat as salvaging the joint can be associated with a high rate of local recurrence (LR). We evaluated the risk factors for tumour relapse after treatment of a GCTB of the limbs.
Anthony M Griffin +2 more
exaly +5 more sources
Current Opinion in Oncology, 2009
Giant cell tumour of bone (GCT) is the most common benign bone tumour and afflicts a young population. Treatment options for patients with unresectable disease have remained fairly static for the past three decades.Recent discoveries have identified a key role for the osteoclast differentiation factor, receptor activator of nuclear factor kappa B (NF ...
David M, Thomas, Keith M, Skubitz
openaire +2 more sources
Giant cell tumour of bone (GCT) is the most common benign bone tumour and afflicts a young population. Treatment options for patients with unresectable disease have remained fairly static for the past three decades.Recent discoveries have identified a key role for the osteoclast differentiation factor, receptor activator of nuclear factor kappa B (NF ...
David M, Thomas, Keith M, Skubitz
openaire +2 more sources
An unusual giant cell tumour of bone
International Orthopaedics, 1981This is a report of an 18-year old girl with an unusual giant cell tumour. Although it is difficult to distinguish between a multifocal giant cell tumour of bone and a primary giant cell tumour with metastases in other bones, we believe that our case is either a multicentric or a multifocal giant cell tumour.
Bose, K., Sinniah, R.
openaire +2 more sources

